NNIT NNIT A/S

NNIT A/S: Financial report for the first six months of 2022

NNIT A/S: Financial report for the first six months of 2022

NNIT announced the transformative divestment of the Group’s infrastructure business, initiated the carve-out process and continued the efforts to consolidate global delivery capabilities in Q2 2022, which was marked by slower-than-expected sales performance. The temporary suspension of NNIT’s full-year outlook is maintained.

Financial highlights for the second quarter 2022

  • Group revenue increased 1.8% (-6.8% organic) to DKK 723 million driven by acquisitions and moderate growth in Life Sciences Solutions outweighed by slow sales overall and lower revenue from the Global Infrastructure Agreement with Novo Nordisk.
  • The operating profit before special items decreased to DKK -11 million from DKK 36 million impacted by the renegotiated Novo Nordisk contract and temporarily lower capacity utilization. The operating profit margin declined to -1.5% before special items from 5.1% in Q2 2021.
  • Special items amounted to DKK 36 million and related mainly to restructuring costs, including costs related to the divestment of infrastructure operations.
  • The Group’s infrastructure operations remain classified as continuing operations due the current state of the business and the ongoing carve-out work. Besides that, to increase transparency certain cost components from Group Companies have been reclassified to Sales and Administration costs from Production costs.

Business highlights

  • On 22 June, NNIT entered into an agreement to divest its Hybrid Cloud Solutions business unit as well as selected parts of its Cloud & Digital Solutions business unit, enabling the NNIT Group to center investments, competencies and sales force around the two core business areas, Life Sciences Solutions and Cloud & Digital Solutions.
  • NNIT won a major six-year contract for delivery of administrative IT systems and services to Danmarks Nationalbank with an estimated total contract value of DKK 1 billion and secured other significant contracts and renewals across business units in the quarter.
  • The order backlog for 2022 stood at DKK 2,572 million at the end of June, corresponding to a decrease of 2.7% compared to the same time last year and an increase of 28% from the beginning of the year.

Outlook

  • The temporary suspension of NNIT’s 2022 outlook is maintained.

Pär Fors, CEO of NNIT, comments: "We took important steps in our strategy execution in the second quarter as we launched the transformative divestment of our infrastructure business to establish NNIT as a highly specialized IT services provider focusing exclusively on our core areas within IT services to the Life Sciences market and Cloud & Digital Solutions. While sales remained slower than expected in the quarter, we expect continued performance improvements and improved capacity utilization in the coming period."

Conference call

On August 12, 2022 at 9:30 CET, NNIT hosts a teleconference, which can be accessed or at under ‘Investors – Events & Presentations’.

Contacts for further information

Pernille Fabricius, EVP & CFO

Tel:

Tina Joanne Hindsbo, Media Relations Manager

Tel:

The NNIT Group provides a wide range of IT and consulting services internationally.

In Denmark, where the Group HQ is based, we are one of the leading IT companies, servicing both private and public sector customers across all industries. In the rest of Europe, Asia and USA, we are solely focused on companies within life sciences.

Supporting the entire supply chain, we help optimize internal company processes, production, sales and customer experiences:

We advise, build, operate and support, enabling digital transformation and customers to reap the full potential of their organizations. Our role is to foster innovation and make the mark our customers and we aspire to.

The NNIT Group consists of group company NNIT A/S and subsidiaries Valiance, SCALES Excellis Health Solutions, SL Controls, and prime4services. Read more at .

Attachment



EN
12/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on NNIT A/S

 PRESS RELEASE

NNIT A/S: NNIT shares its financial calendar for 2026

NNIT A/S: NNIT shares its financial calendar for 2026 The financial calendar for 2026: 28 January 2026Deadline for shareholder proposals for the Annual General Meeting5 February 2026Interim Financial Report Q4 2025 and Annual Report 202512 March 2026Annual General Meeting12 May 2026Interim Financial Report Q1 202627 August 2026Interim Financial Report H1 20265 November 2026Interim Financial Report Q3 2026 For more information, please contact: Investor RelationsCarsten RingiusEVP & CFOTel: Media RelationsThomas StensbølPress & Communications ManagerTel: ABOUT NNIT NNIT is a leadi...

ABGSC IT Research ... (+2)
  • ABGSC IT Research
  • Mikkel Kousgaard Rasmussen
ABGSC IT Research ... (+2)
  • ABGSC IT Research
  • Mikkel Kousgaard Rasmussen
 PRESS RELEASE

NNIT A/S: On-track performance with doubled profitability

NNIT A/S: On-track performance with doubled profitability Q3 2025 key highlights While business was still being negatively impacted by macroeconomic and geopolitical uncertainty, there was an uplift in financial performance in the third quarter. Group operating profit excluding special items more than doubled at DKK 35.6m, corresponding to a margin of 8.2% against 3.9% in the third quarter of 2024. The step-change in margin development compared with last quarter and last year was driven by more efficient operations in terms of improving utilization and the effect from cost reducing initiat...

 PRESS RELEASE

NNIT A/S: NNIT restates its life science segment in its financial repo...

NNIT A/S: NNIT restates its life science segment in its financial reporting structure Today, NNIT announces an update to its financial reporting structure to ensure that all Life Sciences customers are fully consolidated under Region Europe, US, and Asia. As a result, all Life Science customers previously reported under Region Denmark irrespective of the business activity will now be included in Region Europe’s profit and loss statement. Going forward, Region Denmark will consist solely of the Public segment and the Private segment, which includes SCALES. The restatement of the Life Scienc...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch